Medicare Enrolled

Dr. Ravenne Patel, MD

Endocrinology · New Bern, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
702 NEWMAN RD, New Bern, NC 28562
2526335333
Registered in NPPES since 2015
NPI: 1720465610 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Ravenne Patel is an endocrinology specialist in New Bern, NC, with 11 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 5,229 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Patel received a total of $5,142 from 50 pharmaceutical and/or device companies across 285 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years of NPI registration ▲ Top 17% volume in NC $5,142 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
5,229
Medicare services
Top 17% in NC for endocrinology
Not available
Unique patients (not deduplicated)
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,020 $18 $35
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
855 $35 $175
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
558 $82 $244
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
539 $8 $12
Trabecular bone score calculation
This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk.
370 $28 $76
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
299 $9 $30
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
255 $10 $32
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
255 $16 $62
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
155 $116 $316
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
151 $9 $28
Total T3 thyroid hormone test
A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels.
147 $14 $45
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
144 $24 $70
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
107 $6 $18
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
107 $5 $16
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
94 $13 $40
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
62 $48 $200
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
47 $10 $40
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
35 $25 $78
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
16 $102 $250
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $63 $173
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,142
Total received (2018-2024)
Avg $735/year across 7 years
Top 34% in NC for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
285
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,306
2023
$828
2022
$1,889
2021
$776
2020
$73
2019
$169
2018
$101

Payments by company (2024)

Corcept Therapeutics
$185
Amgen Inc.
$167
Lilly USA, LLC
$161
Bayer Healthcare Pharmaceuticals Inc.
$144
Insulet Corporation
$129
Xeris Pharmaceuticals, Inc.
$102
Abbott Laboratories
$81
Novo Nordisk Inc
$60
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Lundbeck LLC
$54
Radius Health, Inc.
$36
Alexion Pharmaceuticals, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$21
Grifols USA, LLC
$17
Regeneron Healthcare Solutions, Inc.
$17
Janssen Biotech, Inc.
$15
Actelion Pharmaceuticals US, Inc.
$14
Astellas Pharma US Inc
$14
Organon Llc
$12
Top 3 companies account for 39.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$586
Corcept Therapeutics
$575
AstraZeneca Pharmaceuticals LP
$470
Lilly USA, LLC
$388
Abbott Laboratories
$315
SANOFI-AVENTIS U.S. LLC
$269
Boehringer Ingelheim Pharmaceuticals, Inc.
$254
Bayer HealthCare Pharmaceuticals Inc.
$217
Novo Nordisk Inc
$187
Bayer Healthcare Pharmaceuticals Inc.
$184
Insulet Corporation
$177
Medtronic MiniMed, Inc.
$169
Grifols USA, LLC
$130
Actelion Pharmaceuticals US, Inc.
$116
Xeris Pharmaceuticals, Inc.
$102
Janssen Biotech, Inc.
$95
Dexcom, Inc.
$93
Radius Health, Inc.
$79
Alexion Pharmaceuticals, Inc.
$59
Lundbeck LLC
$54
Amarin Pharma Inc.
$51
UCB, Inc.
$44
DEXCOM, INC.
$33
Amneal Pharmaceuticals LLC
$32
Medtronic, Inc.
$30
Pharmacosmos Therapeutics Inc.
$28
Biohaven Pharmaceuticals, Inc.
$25
Amryt Pharma Holdings Ltd
$24
Esperion Therapeutics, Inc.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$20
Eisai Inc.
$19
Organon LLC
$19
Nestle HealthCare Nutrition Inc.
$19
MannKind Corporation
$19
Arbor Pharmaceuticals, Inc.
$19
Avanir Pharmaceuticals, Inc.
$18
CSL Behring
$18
Regeneron Healthcare Solutions, Inc.
$17
GRT US Holding, Inc.
$15
Tandem Diabetes Care, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
RECORDATI_RARE_DISEASES_INC.
$15
EUSA Pharma (US) LLC
$15
Ultragenyx Pharmaceutical Inc.
$14
Astellas Pharma US Inc
$14
Daiichi Sankyo Inc.
$13
JAZZ PHARMACEUTICALS INC.
$13
Biohaven Pharmaceutical Holding Company Ltd.
$13
Organon Llc
$12
PFIZER INC.
$12
Top 3 companies account for 31.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · Briviact · Cimzia · Cryvista · DEXCOM G6 TRANSMITTER · DUPIXENT · Dexcom G6 Transmitter · EMGALITY · EVENITY · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · HADLIMA · HUMULIN · Hizentra · Horizant · INJECTAFER · INTELLIS ADAPTIVESTIM · ISTURISA · JARDIANCE · Kerendia · Korlym · LOKELMA · Leqembi · Livalo · MINIMED 770G · MONOFERRIC · MOUNJARO · MYALEPT · Minimed 670G System · NEXLETOL · NURTEC ODT · Nuedexta · OPSUMIT · Omnipod · Otezla · Ozempic · PREVNAR 20 · Prolastin-C Liquid · Qutenza · RENFLEXIS · Repatha · Rybelsus · SOLIQUA 100/33 · SUNOSI · Saxenda · Sylvant · TOUJEO · TREMFYA · TRULICITY · TZIELD · Tymlos · ULTOMIRIS · UNITHROID · VYEPTI · Vascepa · Veozah · XIFAXAN · Xembify · ZENPEP · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in New Bern?
Compare endocrinologists in the New Bern area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
4
County median income
$64,635
Nearest hospital to ZIP centroid (approximate)
CAROLINA EAST MEDICAL CENTER
8.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 17% in NC).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Patel performed 1,020 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $5,142 from 50 companies across 285 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other endocrinologists in New Bern?
Dr. Patel's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →